Ms Carol Joan Goldblatt I, RN, MS, APNC | |
117-119 Roosevelt Ave, Plainfield, NJ 07060 | |
(908) 756-6870 | |
(908) 756-5566 |
Full Name | Ms Carol Joan Goldblatt I |
---|---|
Gender | Female |
Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Adult |
Location | 117-119 Roosevelt Ave, Plainfield, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083762173 | NPI | - | NPPES |
6629806 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | 26NC03900200 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Carol Joan Goldblatt I, RN, MS, APNC 162 Jupitor St, Clark, NJ 07066-3018 Ph: (732) 396-3149 | Ms Carol Joan Goldblatt I, RN, MS, APNC 117-119 Roosevelt Ave, Plainfield, NJ 07060 Ph: (908) 756-6870 |
News Archive
The brains of people with anorexia and obesity are wired differently, according to new research. Neuroscientists for the first time have found that how our brains respond to food differs across a spectrum of eating behaviors - from extreme overeating to food deprivation.
The sweeping extent to which increasing 40Hz "gamma" rhythm power in the brain can affect the pathology and symptoms of Alzheimer's disease in mouse models has been surprising, even to the MIT neuroscientists who've pioneered the idea. So surprising, in fact, they can't yet explain why it happens.
What if the use of a product influenced your perception of it, making you even more susceptible to its positive aspects and altering your understanding of its drawbacks? This is precisely what happens with cigarettes in chronic smokers, according to a recent study by the Institut universitaire en santé mentale de Montréal and University of Montreal.
Merck & Co., Inc., known outside the U.S. and Canada as MSD, today provided further detail on integration plans for the company's research and development, manufacturing and other business operations as part of a global restructuring program announced following the November 2009 merger of Merck and Schering-Plough.
› Verified 8 days ago